These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8359864)

  • 1. Induction of experimental autoimmune myasthenia gravis with acetylcholine receptors using a nonionic block copolymer as adjuvant.
    Shenoy M; Christadoss P
    Immunol Invest; 1993 Jun; 22(4):267-82. PubMed ID: 8359864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental autoimmune myasthenia gravis induced in mice without adjuvant: genetic susceptibility and adoptive transfer of weakness.
    Jermy AC; Fisher CA; Vincent AC; Willcox NA; Newsom-Davis J
    J Autoimmun; 1989 Oct; 2(5):675-88. PubMed ID: 2803477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immune response to acetylcholine receptors in murine experimental autoimmune myasthenia gravis: inhibition with monoclonal anti-I-A antibodies.
    Christadoss P; Lindstrom J; Talal N
    Cell Immunol; 1983 Oct; 81(1):1-8. PubMed ID: 6577968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice.
    Balasa B; Deng C; Lee J; Bradley LM; Dalton DK; Christadoss P; Sarvetnick N
    J Exp Med; 1997 Aug; 186(3):385-91. PubMed ID: 9236190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4 costimulation is not required in a novel LPS-enhanced model of myasthenia gravis.
    Allman W; Qi H; Saini SS; Li J; Tuzun E; Christadoss P
    J Neuroimmunol; 2012 Aug; 249(1-2):1-7. PubMed ID: 22626443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor.
    Wang ZY; Qiao J; Link H
    J Neuroimmunol; 1993 May; 44(2):209-14. PubMed ID: 8505410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Huang J; Olsson T; He B; Link H
    J Neurol Sci; 1995 Feb; 128(2):167-74. PubMed ID: 7537794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injection of inactive Bordetella pertussis and complete Freund's adjuvant with Torpedo californica AChR increases the occurrence of experimental autoimmune myasthenia gravis in C57BL/6 mice.
    Maruta T; Oshima M; Mosier DR; Atassi MZ
    Autoimmunity; 2017 Aug; 50(5):293-305. PubMed ID: 28548588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell autoimmunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis.
    Wang ZY; Link H; Qiao J; Olsson T; Huang WX
    J Neuroimmunol; 1993 Jun; 45(1-2):103-12. PubMed ID: 8331155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic murine experimental myasthenia gravis: strength testing and serology.
    Pachner AR; Itano A; Ricalton N; Choe S
    Clin Immunol Immunopathol; 1991 Jun; 59(3):398-406. PubMed ID: 2029792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
    Ulusoy C; Çavuş F; Yılmaz V; Tüzün E
    Immunol Invest; 2017 Jul; 46(5):490-499. PubMed ID: 28375749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How subtle differences in MHC class II affect the severity of experimental myasthenia gravis.
    Yang B; McIntosh KR; Drachman DB
    Clin Immunol Immunopathol; 1998 Jan; 86(1):45-58. PubMed ID: 9434796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats.
    Zhang GX; Ma CG; Xiao BG; Bakhiet M; Link H; Olsson T
    Eur J Immunol; 1995 May; 25(5):1191-8. PubMed ID: 7774622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis.
    Pachner AR; Kantor FS
    Clin Exp Immunol; 1984 Jun; 56(3):659-68. PubMed ID: 6235071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental myasthenia gravis. A murine system.
    Berman PW; Patrick J
    J Exp Med; 1980 Jan; 151(1):204-23. PubMed ID: 7350247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors in the production of experimental autoimmune myasthenia gravis in acetylcholine receptor immunized rabbits.
    Niemi WD; Nastuk WL; Chang HW; Plescia OJ; Plescia AM
    Ann N Y Acad Sci; 1981; 377():222-36. PubMed ID: 6951475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravis.
    Wang HB; Shi FD; Li H; Chambers BJ; Link H; Ljunggren HG
    J Immunol; 2001 May; 166(10):6430-6. PubMed ID: 11342669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulation of experimental autoimmune myasthenia gravis with linomide.
    Karussis DM; Lehmann D; Brenner T; Wirguin I; Mizrachi-Koll R; Sicsic C; Abramsky O
    J Neuroimmunol; 1994 Dec; 55(2):187-93. PubMed ID: 7829669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor.
    Araga S; LeBoeuf RD; Blalock JE
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8747-51. PubMed ID: 8378359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor.
    Shenoy M; Oshima M; Atassi MZ; Christadoss P
    Clin Immunol Immunopathol; 1993 Mar; 66(3):230-8. PubMed ID: 7679342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.